Methods and materials for alleviation of pain symptoms of malignant neoplasia
US4689222A · kind A · utility
32Cited by
9References
2Claims
0Family size
Inventor
Key dates
| Filing date | Dec 9, 1985 |
| Grant date | Aug 25, 1987 |
| Priority date | — |
| Expiry date | Dec 9, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method and composition useful for the alleviation of pain symptoms associated with malignant neoplasia and acquired immune deficiency syndrome by once daily administration of a substance (such as human chorionic gonadotropin) characteristic of the tumor or acquired immune deficiency syndrome-afflicted cell in an amount less that the lowest amount necessary to provoke a humoral immune response, as exemplified by the existence of a negative wheal upon subcutaneous administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.